[Hyperbaric oxygen therapy for radiation-induced cystitis]

Dalsbø TK, Desser AS, Kornør H
Record ID 32018000913
Original Title: Hyperbar oksygenbehandling av kronisk strålecystitt. Forenklet metodevurdering
Authors' results and conclusions: Hyperbaric oxygen treatment is a possible treatment option for radiation-induced cystitis following cancer treatment in the pelvic area. Patients receiving hyperbaric oxygen treatment breathe pure oxygen in a high-pressure chamber. The treatment session lasts for approximately one to two, and is provided five to seven days per week, 30 to 40 treatments in total. The evidence base for effects of hyperbaric oxygen treatment consists of two, small randomised controlled trials. Hyperbaric oxygen treatment compared to standard treatment (not specified): Probably slightly improves quality of life Probably improves urinary symptoms May not make any difference in pain as measured by SF-36 It is uncertain whether there is any difference in effects between hyperbaric oxygen treatment and hyaluronic acid in patients with haemorrhagic cystitis. A simplified economic assessment shows: Total cost per patient is NOK 116 010 Five-year budget impact is NOK 16 010 133 To conduct a health economic analysis that can address the priority criteria for severity and resource use, better information is needed about disease progression, current standard treatment and quality-of-life expressed as utility weights.
Project Status: Completed
Year Published: 2020
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Norway
MeSH Terms
  • Hyperbaric Oxygenation
  • Cystitis
  • Radiation Injuries
Organisation Name: Norwegian Institute of Public Health
Contact Address: P.O. Box 222 Skoyen, N-0123, Oslo
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.